We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

48 hedge funds and large institutions have $17.3M invested in IVERIC bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 52 → 48 (-4)

18% less capital invested

Capital invested by funds: $21.2M → $17.3M (-$3.91M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

71% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 17

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
5
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$35.6K
2
Goldman Sachs
Goldman Sachs
New York
+$34.2K
3
Morgan Stanley
Morgan Stanley
New York
+$10.1K
4
Victory Capital Management
Victory Capital Management
Texas
+$6.93K
5
Bank of America
Bank of America
North Carolina
+$5.52K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$335K
2
JP Morgan Chase
JP Morgan Chase
New York
-$176K
3
Deutsche Bank
Deutsche Bank
Germany
-$153K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$109K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$98.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$4.29M -$335K -287,619 -7%
TA
2
Tamarack Advisers
California
$3.36M – – –
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$1.39M -$23.4K -20,078 -2%
Renaissance Technologies
4
Renaissance Technologies
New York
$1.34M -$41K -35,246 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.31M +$35.6K +30,608 +3%
Connor, Clark & Lunn Investment Management (CC&L)
6
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$868K -$109K -93,400 -11%
Morgan Stanley
7
Morgan Stanley
New York
$845K +$10.1K +8,722 +1%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$763K – – –
BlackRock
9
BlackRock
New York
$732K -$5.55K -4,767 -0.7%
TCM
10
Tang Capital Management
California
$672K – – –
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$274K – – –
Assenagon Asset Management
12
Assenagon Asset Management
Luxembourg
$242K -$20.3K -17,489 -7%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$194K – – –
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$183K -$98.6K -84,779 -34%
Two Sigma Investments
15
Two Sigma Investments
New York
$133K -$24.5K -21,033 -15%
BFM
16
Boothbay Fund Management
New York
$105K – – –
SXL
17
Summit X LLC
Missouri
$100K +$3.49K +3,000 +3%
Northern Trust
18
Northern Trust
Illinois
$97K – – –
Creative Planning
19
Creative Planning
Kansas
$62K – – –
Two Sigma Advisers
20
Two Sigma Advisers
New York
$52K -$12.3K -10,600 -19%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$49K – – –
State Street
22
State Street
Massachusetts
$47K – – –
BCM
23
Bridgeway Capital Management
Texas
$45K – – –
BIM
24
Bogle Investment Management
Massachusetts
$33K – – –
Goldman Sachs
25
Goldman Sachs
New York
$33K +$34.2K +29,370 New
1
2 3

ISEE Hedge Fund Activity: Q3 2019 in Review

48 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2019, worth a combined $17.3M — down 18% from $21.2M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ISEE and 4 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $35.6K. The largest seller was Stonepine Capital Management, cutting an estimated $335K.

  • 48 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2019, down from 52 in Q2 2019.
  • Funds reported $17.3M of IVERIC bio, Inc. Common Stock stock for Q3 2019, down 18% quarter-over-quarter.
  • 4 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2019 and 8 closed out, a net change of -4 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2019 was Vanguard Group, an estimated $35.6K added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2019 was Stonepine Capital Management, an estimated $335K sold.

Based on aggregated 13F filings for Q3 2019.